recipients, and renal transplants which has successfully completed phase IV in 2013.
Furthermore, growing demand for kidney transplants is expected to propel growth of the global
sirolimus market growth over the forecast period. According to the National Kidney Foundation,
2014 in U.S. data, every month approximately 3,000 patients were added to the kidney
transplant waiting list, and an estimated 13 people died each day while waiting for a life-saving
kidney transplant.
Global Sirolimus Market Restraints
Some of the factors restraining the global sirolimus market growth are the side effects
associated with sirolimus such as increased susceptibility to infection, malignancy,
hypertriglyceridemia, hypercholesterolemia, angioedema, and proteinuria. Administering
sirolimus to patients undergoing liver and lung transplants is generally avoided owing to side
effects such as hyperlipidemia and hepatic artery thrombosis.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/sirolimus-market-2842
Global Sirolimus Market Key Players
Some of the major players operating in the global sirolimus market include Pfizer Inc., Actiza,
Zydus Cadila Healthcare Ltd., Inc., Greenstone Llc., Biocon, Livzon NNR, and Intas
Pharmaceuticals Ltd.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702